ANG II and calmodulin/CaMKII regulate surface expression and functional activity of NBCe1 via separate means.
We recently reported that ANG II inhibits NBCe1 current and surface expression in Xenopus laevis oocytes (Perry C, Blaine J, Le H, and Grichtchenko II. Am J Physiol Renal Physiol 290: F417-F427, 2006). Here, we investigated mechanisms of ANG II-induced changes in NBCe1 surface expression. We showed that the PKC inhibitor GF109203X blocks and EGTA reduces surface cotransporter loss in ANG II-treated oocytes, suggesting roles for PKC and Ca(2+). Using the endosomal marker FM 4-64 and enhanced green fluorescent protein (EGFP)-tagged NBCe1, we showed that ANG II stimulates endocytosis of NBCe1. To eliminate the possibility that ANG II inhibits NBCe1 recycling, we demonstrated that the recycling inhibitor monensin decreases surface expression, accumulates NBCe1-EGFP in endosomes, and inhibits NBCe1 current. Monensin and ANG II applied together produce greater inhibition of NBCe1 current than either did alone. This additive effect of monensin and ANG II suggests that ANG II stimulates internalization of NBCe1. We used the calmodulin (CaM) antagonist W13, which controls recycling by blocking the exit of the endocytosed cargo from early endosomes, to determine the role of CaM in NBCe1 trafficking. We demonstrated that W13 decreases surface expression of NBCe1, accumulates NBCe1-EGFP in endosomal-like formations, and inhibits NBCe1 current. W13 and ANG II applied together produce greater inhibition of NBCe1 current than either does alone, while W13 and monensin applied together do not. The additive effect of ANG II and W13 and lack of additive effect of monensin and W13 suggest that CaM is not involved in ANG II stimulation of internalization but controls recycling of endocytosed NBCe1. The CaM-activated enzyme CaM kinase II (CaMKII) applied with ANG II also gives an additive inhibitory effect, suggesting a role for CaMKII in NBCe1 recycling.
Perry
Clint
C
Department of Physiology and Biophysics, University of Colorado and Denver Health Sciences Center, Aurora, CO 80045, USA.
Le
Hong
H
Grichtchenko
Irina I
II
D000804:Angiotensin II / Q000502:physiology*; D000818:Animals; D001596:Benzylamines / Q000494:pharmacology; D001710:Biotin / Q000502:physiology; D002118:Calcium / Q000502:physiology; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*; D002147:Calmodulin / Q000037:antagonists & inhibitors / Q000502:physiology*; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D005260:Female; D005456:Fluorescent Dyes; D006801:Humans; D007476:Ionophores / Q000494:pharmacology; D018613:Microscopy, Confocal; D008985:Monensin / Q000494:pharmacology; D009865:Oocytes / Q000378:metabolism; D018408:Patch-Clamp Techniques; D011493:Protein Kinase C / Q000378:metabolism; D027982:Sodium-Bicarbonate Symporters / Q000502:physiology*; D013449:Sulfonamides / Q000494:pharmacology; D029867:Xenopus Proteins / Q000502:physiology*; D014982:Xenopus laevis; D000096926:Benzenesulfonamides
D000804:Angiotensin II; D001596:Benzylamines; D001710:Biotin; D002118:Calcium; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D002147:Calmodulin; D018076:DNA, Complementary; D005456:Fluorescent Dyes; D007476:Ionophores; D008985:Monensin; D011493:Protein Kinase C; D027982:Sodium-Bicarbonate Symporters; D013449:Sulfonamides; D029867:Xenopus Proteins; C522009:SLC4A4 protein, Xenopus; C072105:KN 93; D000096926:Benzenesulfonamides; C033772:N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide